Augmentation of EPR Effect and Efficacy of Anticancer Nanomedicine by Carbon Monoxide Generating Agents.

Fang, Jun; Islam, Rayhanul; Islam, Waliul; Yin, Hongzhuan; Subr, Vladimir; Etrych, Tomas; Ulbrich, Karel; Maeda, Hiroshi

Fang, Jun; Islam, Rayhanul; Islam, Waliul; Yin, Hongzhuan; Subr, Vladimir; Etrych, Tomas; Ulbrich, Karel; Maeda, Hiroshi.

Affiliation

Fang J; Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto 860-0082, Japan. fangjun@ph.sojo-u.ac.jp.
Islam R; Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto 860-0082, Japan.
Islam W; Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
Yin H; Biodynamics Research Foundation, Kumamoto 862-0954, Japan.
Subr V; Faculty of Pharmaceutical Sciences, Sojo University, Kumamoto 860-0082, Japan.
Etrych T; Department of General Surgery, Sheng Jing Hospital, China Medical University, Shenyang 110011, China.
Ulbrich K; Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague 16206, Czech Republic.
Maeda H; Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague 16206, Czech Republic.

Pharmaceutics ; 11(7)2019 Jul 16.

Article de En | MEDLINE | ID: mdl-31315251

Mots clés

EPR effect; PDT; carbon monoxide; nanomedicine; nanoprobe

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Pharmaceutics Année: 2019 Type de document: Article Pays d'affiliation: Japon Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google